Table 3.
25(OH)D levels (nmol/L) | Person-years | Incident cases | Incidence density (/103 PY) | Age- and sex-adjusted HR (95% CI) | Multivariable-adjusted HRa (95% CI) | HR (95% CI)b in a model with time-dependent variables | ||
---|---|---|---|---|---|---|---|---|
Visit 1 | Visit 2 | Model 1 | Model 2 | |||||
Total | ||||||||
<50 | <50 | 212,785.0 | 4157 | 19.5 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
≥50 | <50 | 33,319.2 | 556 | 16.7 | 0.85 (0.78–0.93) | 0.85 (0.78–0.93) | 0.84 (0.77–0.92) | 0.86 (0.78–0.94) |
<50 | ≥50 | 63,741.6 | 1001 | 15.7 | 0.80 (0.75–0.86) | 0.85 (0.80–0.92) | 0.85 (0.79–0.91) | 0.87 (0.81–0.93) |
≥50 | ≥50 | 60,559.7 | 956 | 15.8 | 0.79 (0.74–0.85) | 0.81 (0.75–0.87) | 0.81 (0.75–0.87) | 0.84 (0.78–0.90) |
Women | ||||||||
<50 | <50 | 101,903.1 | 2262 | 22.2 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
≥50 | <50 | 10,964.2 | 201 | 18.3 | 0.83 (0.72–0.95) | 0.81 (0.70–0.93) | 0.88 (0.76–1.02) | 0.87 (0.75–1.01) |
<50 | ≥50 | 25,365.8 | 410 | 16.2 | 0.73 (0.66–0.81) | 0.76 (0.69–0.85) | 0.80 (0.72–0.89) | 0.84 (0.75–0.93) |
≥50 | ≥50 | 15,201.1 | 257 | 16.9 | 0.75 (0.66–0.85) | 0.75 (0.66–0.86) | 0.83 (0.72–0.94) | 0.89 (0.78–1.01) |
Men | ||||||||
<50 | <50 | 110,881.9 | 1895 | 17.1 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
≥50 | <50 | 22,355.0 | 355 | 15.9 | 0.93 (0.83–1.04) | 0.84 (0.75–0.94) | 0.83 (0.74–0.93) | 0.85 (0.76–0.95) |
<50 | ≥50 | 38,375.8 | 591 | 15.4 | 0.90 (0.82–0.99) | 0.93 (0.85–1.03) | 0.90 (0.82–0.98) | 0.89 (0.81–0.97) |
≥50 | ≥50 | 45,358.6 | 699 | 15.4 | 0.88 (0.81–0.97) | 0.82 (0.75–0.90) | 0.80 (0.74–0.88) | 0.82 (0.76–0.90) |
aEstimated using Cox proportional hazard models. The multivariable model 1 was adjusted for age, sex, centre, year of screening examination, alcohol consumption, smoking, physical activity, total energy intake, education level, and BMI; model 2: model 1 plus adjustment for medication for hyperlipidaemia, medication for diabetes, multivitamin supplement, vitamin D supplement, and calcium supplement. bEstimated using Cox proportional hazard models with categories of serum 25(OH)D levels, smoking, alcohol consumption, physical activity, total energy intake, BMI, medication for hyperlipidaemia, medication for hyperlipidaemia, medication for diabetes, multivitamin supplement, vitamin D supplement, and calcium supplement as time-dependent variables and baseline age, centre, year of screening examination, and education level as time-fixed variables.
HR, hazards ratio; LMM, low muscle mass; PY, person-years.